AIM
LEGN icon

Aigen Investment Management’s Legend Biotech LEGN Stock Holding History

Aigen Investment Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,894
Closed -$584K – 821
2025
Q3 		$584K Buy
+17,894
New +$661K 0.09% 353
2025
Q1 		– Sell
-7,363
Closed -$240K – 899
2024
Q4 		$240K Buy
7,363
+1,206
+20% +$50K 0.04% 552
2024
Q3 		$300K Buy
+6,157
New +$328K 0.06% 472
2023
Q4 		– Sell
-4,765
Closed -$320K – 939
2023
Q3 		$320K Sell
4,765
-8,571
-64% -$595K 0.06% 502
2023
Q2 		$921K Buy
+13,336
New +$871K 0.14% 218
2021
Q3 		– Sell
-5,628
Closed -$231K – 578
2021
Q2 		$231K Buy
+5,628
New +$191K 0.04% 378

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aigen Investment Management's LEGN Position: Q4 2025 in Review

Aigen Investment Management sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 17,894 shares — an estimated $584K sold.

Aigen Investment Management first reported a position in LEGN in Q2 2021 and held it in 6 quarters. The position peaked at $921K in Q2 2023. 198 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Aigen Investment Management reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 17,894 Legend Biotech shares in Q4 2025, an estimated $584K.
  • Aigen Investment Management first reported a position in Legend Biotech in Q2 2021 and held it in 6 quarters.
  • Aigen Investment Management's Legend Biotech position peaked at $921K in Q2 2023.
  • 198 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.